deco wave


Swoop™ is the brainchild of Hyperfine, a company founded in 2014 by longtime scientist-inventor Dr. Jonathan Rothberg, who developed high-speed DNA sequencing and the world’s best-selling point-of-care ultrasound, the Butterfly iQ.

At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe.

While the Hyperfine team kept the fundamental principles of MRI and its core components, they turned just about everything else about MRI on its head. The team designed for simplicity while leveraging the million-fold improvement in computing power since the first MRI systems were designed over 40 years ago.

Hyperfine produced its first images within a year of the company’s founding, and since then, it has rapidly advanced image quality and functionality.

Today, Swoop™ is the first portable, easy-to-use MRI system in the world.

Interested in joining our pioneering team? Reach out today.

NOTE: Deployed Gauss guard (not shown) delineates the 5 Gauss boundary and must be extended during transport and use.

Leadership Team

Jonathan Rothberg, PhD

Serial entrepreneur, founded and invented massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip (Butterfly Network); awarded the National Medal of Technology and Innovation by US President Barack Obama. Yale University PhD, MS, MPhil; Carnegie Mellon BS.

Mark Hughes
Chief Operating Officer

20+ years leading R&D and start-ups at Thermo Fisher Scientific, Life Technologies / Ion Torrent, Lucent Technologies / Sycamore Networks / Sirocco Systems, Sahara Networks; experience at Raytheon, GTE, Motorola; University of Rhode Island BS EE / MBA.

Khan Siddiqui, MD
Chief Medical Officer / Chief Strategy Officer

Serial entrepreneur; board-certified radiologist with leadership experience at Johns Hopkins University and University of Maryland; American College of Radiology Informatics Commission; Microsoft R&D leader; Founder, CTO, and Chief Medical Officer of higi.

Chris Ward

20-year medical device marketing leader, divisional Chief Marketing Officer at GE Healthcare, VP US Marketing at Medtronic; Vanderbilt University MBA.

Brian Welch, PhD, MBA
Director of Clinical Science

23-year veteran of medical imaging, including Philips Healthcare, Vanderbilt University Medical Center; Mayo Clinic College of Medicine PhD, University of Southern California BS, Tennessee Technological University MBA.

Michael Poole, PhD
Product Development

Co-founder at Hyperfine and 17 years of MRI development in academia and industry, including fellowships at Forschungszentrum Jülich, University of Queensland, and the Sir Peter Mansfield MR Centre; University of Nottingham PhD.

Our Mission

Male patient in gown waiting in exam room

Hyperfine began from our personal experience with the extraordinary power—and many challenges—of conventional MRI.

Despite being one of the safest and most informative imaging modalities available, MRI is accessible to just a small percentage of patients. Globally, some 4.7 billion people lack access to any form of medical imaging. For MRI, the picture is even bleaker: the World Health Organization estimates that just 10% of the world’s population has access to MRI (2008).

Even in the countries in which it is present, MRI is expensive, complicated, and stressful for the patient.

Our core mission at Hyperfine is to make MRI accessible to every patient, regardless of income or resources. Anytime. Anywhere.

Get the specifics on what makes Swoop™ a breakthrough device.

What Others Say

  • “[We] believe that the global MRI market is on the brink of a new era as word of the once ‘mythical’ affordable and portable MRI spreads. With its groundbreaking design, Hyperfine’s portable MRI can extend access to cost-effective imaging and, subsequently, its clinical utility and healthcare value across medical applications, clinical specialties and settings, and geographical regions worldwide.”
    —Frost & Sullivan, 2020

Hyperfine is part of the 4Catalyzer family of companies. 4Catalyzer is a health technology incubator with facilities in Connecticut, New York City, Palo Alto, and Taiwan. The mission of 4Catalyzer is to make healthcare more accessible and maximize societal impact.